Oncology
Lunchtime session
Lung cancer: latest developments in screening and patient management
Clinical
ERS/Lancet joint lunchtime
Aims : The aim of this session is to learn about the latest treatments, clinical developments, and thinking in the area of lung cancer screening, management, and treatment.
13:00
Lung cancer screening: latest developments and unanswered questions
C. Van der Aalst(Rotterdam, Netherlands)
COI
1
2905
13:22
New and emerging targeted treatments in advanced lung cancer
F. Hirsch(Aurora, United States)
COI
2
2906
13:44
Challenges in molecular testing in lung cancer patients with advanced disease
R. Sharpe(London, United Kingdom)
COI
3
2907
14:06
Results from the UK Medical Research Council QUARTZ randomised controlled trial in patients with NSCLC
P. Mulvenna(Newcastle upon Tyne (Tyne and Wear), United Kingdom)
COI
4
2908
. . .
